Waning immunity and IgG4 responses following bivalent mRNA boosting

Author:

Lasrado Ninaad1ORCID,Collier Ai-ris Y.1ORCID,Miller Jessica1ORCID,Hachmann Nicole P.1ORCID,Liu Jinyan1ORCID,Anand Trisha1ORCID,A. Bondzie Esther1ORCID,Fisher Jana L.1,Mazurek Camille R.1ORCID,Patio Robert C.1ORCID,Rodrigues Stefanie L.1,Rowe Marjorie1,Surve Nehalee1ORCID,Ty Darren M.1ORCID,Wu Cindy1ORCID,Chicz Taras M.2ORCID,Tong Xin2,Korber Bette3ORCID,McNamara Ryan P.2ORCID,Barouch Dan H.12ORCID

Affiliation:

1. Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.

2. Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA, USA.

3. Los Alamos National Laboratory and New Mexico Consortium, Los Alamos, NM, USA.

Abstract

Messenger RNA (mRNA) vaccines were highly effective against the ancestral SARS-CoV-2 strain, but the efficacy of bivalent mRNA boosters against XBB variants was substantially lower. Here, we show limited durability of neutralizing antibody (NAb) responses against XBB variants and isotype switching to immunoglobulin G4 (IgG4) responses following bivalent mRNA boosting. Bivalent mRNA boosting elicited modest XBB.1-, XBB.1.5-, and XBB.1.16-specific NAbs that waned rapidly within 3 months. In contrast, bivalent mRNA boosting induced more robust and sustained NAbs against the ancestral WA1/2020 strain, suggesting immune imprinting. Following bivalent mRNA boosting, serum antibody responses were primarily IgG2 and IgG4 responses with poor Fc functional activity. In contrast, a third monovalent mRNA immunization boosted all isotypes including IgG1 and IgG3 with robust Fc functional activity. These data show substantial immune imprinting for the ancestral spike and isotype switching to IgG4 responses following bivalent mRNA boosting, with important implications for future booster designs and boosting strategies.

Publisher

American Association for the Advancement of Science (AAAS)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3